3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid has been researched along with Kidney Diseases in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grieve, EM; Hawksworth, GM; Simpson, JG; Whiting, PH | 2 |
| Behrend, EN; Fettman, MJ; Getzy, DM; Grauer, GF; Greco, DS; Mani, I; Reinhart, GA | 1 |
| Burdick, JF; Klassen, DK; Weir, MR | 1 |
| Chaland, P; Corman, J; Daloze, P; Douglas, F; Etienne, P; Giroux, L; Moutquin, JM; Smeesters, C; St-Louis, G | 1 |
5 other study(ies) available for 3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid and Kidney Diseases
| Article | Year |
|---|---|
The reversal of experimental cyclosporin A nephrotoxicity by thromboxane synthetase inhibition.
Topics: Animals; Body Weight; Cyclosporine; Enzyme Inhibitors; Kidney Diseases; Male; Prostaglandins; Pyridines; Rats; Rats, Sprague-Dawley; Thromboxane B2; Thromboxane-A Synthase | 1993 |
Effects of dietary n-3 fatty acid supplementation versus thromboxane synthetase inhibition on gentamicin-induced nephrotoxicosis in healthy male dogs.
Topics: Animals; Body Weight; Creatinine; Diet; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Eating; Enzyme Inhibitors; Fatty Acids, Omega-3; Food, Fortified; Gentamicins; Glomerular Filtration Rate; Kidney Cortex; Kidney Diseases; Male; Potassium; Prostaglandins; Protein Synthesis Inhibitors; Pyridines; Random Allocation; Sodium; Thromboxane B2; Thromboxane-A Synthase | 1996 |
A pilot study to assess the ability of an orally available selective thromboxane synthase inhibitor to improve renal function in cyclosporine-treated renal transplant recipients.
Topics: Administration, Oral; Adult; Cyclosporine; Eicosanoids; Female; Hemodynamics; Humans; Kidney; Kidney Diseases; Kidney Transplantation; Male; Pilot Projects; Pyridines; Thromboxane-A Synthase | 1992 |
Effect of thromboxane synthetase inhibition and angiotensin converting enzyme inhibition on acute cyclosporin A nephrotoxicity.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Body Weight; Cyclosporins; Glomerular Filtration Rate; Kidney Diseases; Male; Pyridines; Rats; Rats, Inbred Strains; Thromboxane-A Synthase; Urodynamics | 1990 |
Prevention of acute cyclosporine A nephrotoxicity by a thromboxane synthetase inhibitor.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Creatinine; Cyclosporins; Dinoprostone; Kidney Diseases; Male; Prostaglandins E; Pyridines; Rats; Thromboxane B2; Thromboxane-A Synthase | 1988 |